2022 Episode 6 – Initiative Update

Listen to Eduardo Sanchez, MD, MPH, FAHA and Robert A. Gabbay, MD, PhD give an update on the initiative from launch through 2021 including notable insights, key learnings and future outlook as well as empowering patients to be active members of their health care team.

Play the podcast in Apple Podcasts.

podcast player graphic

2022 Episode 6 – Initiative Update

Download the Episode 6 Transcript

Robert A. Gabbay, MD, PhD is Chief Scientific and Medical Officer of the American Diabetes Association and Associate Professor at Harvard Medical School. His research focuses on innovative models of diabetes care to improve diabetes outcomes and the lives of people with diabetes. Throughout his vibrant career he has had many accomplishments as a basic science researcher, developer of patient communication tools, creator of the first broad scale diabetes registry, designer of care management training programs, and leader of one of the largest primary care transformation efforts in the US around the Patient Centered Medical Home. The reach of his work has been recognized through leadership roles around the world to transform diabetes care including leading the International Diabetes Federation BRIDGES program that implements evidence based translational research to low resource global settings. Dr. Gabbay has received funding from the National Institute of Health Diabetes, Digestive and Kidneys Diseases (NIDDK), the Agency for Healthcare Research and Quality (AHRQ), and the Center for Medicare and Medicaid Innovation for his care transformation work.

Robert A. Gabbay, MD, PhD, Chief Scientific and Medical Officer, American Diabetes Association

Eduardo Sanchez, MD, MPH, FAHA is Chief Medical Officer (CMO) for Prevention for the American Heart Association (AHA). Additionally, He is the Principal Investigator (PI) of the National Hypertension Control Initiative (NHCI), a cooperative agreement with the U.S. Department of Health and Human Services (HHS)  Office of Minority Health (OMH) and the Health Resources and Services Administration (HRSA).  He is the AHA clinical lead on Target:BP (a joint blood pressure control initiative with the American Medical Association) and Know Diabetes by HeartTM (a joint cardiovascular risk factor control initiative with the American Diabetes Association).  He is one of the authors of the AHA Presidential Advisory on Structural Racism and its health effects. He serves on numerous national and state advisory committees. Prior to joining AHA, he served as CMO for Blue Cross and Blue Shield of Texas (BCBSTX). Dr. Sanchez is board certified in family medicine.